Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling

被引:0
|
作者
Yaoxing Wu
Ling Ma
Zhen Zhuang
Sihui Cai
Zhiyao Zhao
Lingli Zhou
Jing Zhang
Pei-Hui Wang
Jincun Zhao
Jun Cui
机构
[1] Sun Yat-sen University,MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences
[2] The First Affiliated Hospital of Guangzhou Medical University,State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease
[3] Shandong University,Advanced Medical Research Institute, Cheeloo College of Medicine
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling
    Wu, Yaoxing
    Ma, Ling
    Zhuang, Zhen
    Cai, Sihui
    Zhao, Zhiyao
    Zhou, Lingli
    Zhang, Jing
    Wang, Pei-Hui
    Zhao, Jincun
    Cui, Jun
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [2] Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication
    Geerling, Elizabeth
    Pinski, Amanda N.
    Stone, Taylor E.
    DiPaolo, Richard J.
    Zulu, Michael Z.
    Maroney, Kevin J.
    Brien, James D.
    Messaoudi, Ilhem
    Pinto, Amelia K.
    ISCIENCE, 2022, 25 (01)
  • [3] Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease
    Sarkar, Arighna
    Mandal, Kalyaneswar
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (44) : 23492 - 23494
  • [4] Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
    Johansen-Leete, Jason
    Ullrich, Sven
    Fry, Sarah E.
    Frkic, Rebecca
    Bedding, Max J.
    Aggarwal, Anupriya
    Ashhurst, Anneliese S.
    Ekanayake, Kasuni B.
    Mahawaththa, Mithun C.
    Sasi, Vishnu M.
    Luedtke, Stephanie
    Ford, Daniel J.
    O'Donoghue, Anthony J.
    Passioura, Toby
    Larance, Mark
    Otting, Gottfried
    Turville, Stuart
    Jackson, Colin J.
    Nitsche, Christoph
    Payne, Richard J.
    CHEMICAL SCIENCE, 2022, 13 (13) : 3826 - 3836
  • [5] Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar antiviral potency
    Zhang, Haoran
    Zhou, Kangping
    Peng, Fei
    Gao, Zhao
    Song, Guowei
    Hu, Bing
    Chun, Sophia
    Xiao, Junfeng
    Qian, Mengfei
    Wu, Jin
    Pan, Kai
    Gao, Fan
    Guo, Meng
    Peng, Cheng
    Zou, Gang
    Wu, Jim Zhen
    Cai, Kun
    Li, Yan
    JOURNAL OF INFECTION, 2024, 88 (02) : 211 - 214
  • [6] Development of Antiviral Cyclic Peptides Targeting the Main Protease of SARS-CoV-2
    Harrison, Katriona
    Johansen-Leete, Jason
    Ullrich, Sven
    Fry, Sarah
    Frkic, Rebecca
    Bedding, Max
    Aggarwale, Anupriya
    Passioura, Toby
    Turville, Stuart
    Jackson, Colin
    Nitsche, Christoph
    Payne, Richard
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28
  • [7] Research Progress of Antiviral Drug Targeting the Main Protease of SARS-CoV-2
    Wang, Chunxia
    Hu, Xiaodong
    Xu, Bin
    Cao, Chunyang
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2022, 42 (07) : 1974 - 1999
  • [8] Evasion of Type I Interferon by SARS-CoV-2
    Xia, Hongjie
    Cao, Zengguo
    Xie, Xuping
    Zhang, Xianwen
    Chen, John Yun-Chung
    Wang, Hualei
    Menachery, Vineet D.
    Rajsbaum, Ricardo
    Shi, Pei-Yong
    CELL REPORTS, 2020, 33 (01):
  • [9] SARS-CoV-2 Main Protease as Target
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1278 - 1278
  • [10] Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
    Zhang, Wenfa
    Lin, Sheng-Xiang
    VIRUSES-BASEL, 2023, 15 (02):